tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RIGL Stock Latest News

Rigel Pharmaceuticals price target raised to $71 from $69 at Citi
The FlyRigel Pharmaceuticals price target raised to $71 from $69 at Citi
17d ago
RIGL
Rigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
PremiumRatings
Rigel: Strengthening Commercial Trajectory, Clear Path to 2026 Profitability, and Advancing Pipeline Support Buy Rating
18d ago
RIGL
Rigel Announces Strong Preliminary 2025 Results and Outlook
PremiumCompany Announcements
Rigel Announces Strong Preliminary 2025 Results and Outlook
19d ago
8K
RIGL
Rigel Pharmaceuticals sees Q4 revenue $69.8M, consensus $66.44M
PremiumThe Fly
Rigel Pharmaceuticals sees Q4 revenue $69.8M, consensus $66.44M
19d ago
RIGL
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $291.58M
PremiumThe Fly
Rigel Pharmaceuticals sees FY26 revenue $275M-$290M, consensus $291.58M
19d ago
RIGL
Rigel Pharmaceuticals Reports Promising Phase 1b Study Results
PremiumCompany AnnouncementsRigel Pharmaceuticals Reports Promising Phase 1b Study Results
2M ago
8K
RIGL
Rigel’s Promising Pipeline and Strategic Advancements Justify Buy Rating
Premium
Ratings
Rigel’s Promising Pipeline and Strategic Advancements Justify Buy Rating
2M ago
RIGL
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891
Premium
The Fly
Rigel Pharmaceuticals announces updated data from Phase 1b study of R2891
2M ago
RIGL
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
PremiumThe Fly
Rigel Pharmaceuticals’ olutasidenib shows efficacy in Phase 2 AML trial
3M ago
RIGL
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
PremiumCompany Announcements
Rigel Pharmaceuticals Reports Record Q3 Revenue and Growth
3M ago
RIGL
Rigel Pharmaceuticals upgraded to Buy at Jefferies on strong execution
PremiumThe Fly
Rigel Pharmaceuticals upgraded to Buy at Jefferies on strong execution
3M ago
RIGL
Rigel Pharmaceuticals upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Rigel Pharmaceuticals upgraded to Buy from Hold at Jefferies
3M ago
RIGL
Midday Fly By: Broader market bought on dip after tech selloff
PremiumThe FlyMidday Fly By: Broader market bought on dip after tech selloff
3M ago
BW
KW
Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
Premium
The Fly
Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
3M ago
RIGL
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
Rigel Pharmaceuticals Reports Strong Q3 2025 Results
3M ago
RIGL
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
PremiumThe Fly
Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
3M ago
RIGL
Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M
PremiumThe Fly
Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M
3M ago
RIGL
Is RIGL a Buy, Before Earnings?
PremiumPre-Earnings
Is RIGL a Buy, Before Earnings?
3M ago
RIGL
Rigel’s Strategic Advancements and Financial Projections Justify Buy Rating
PremiumRatings
Rigel’s Strategic Advancements and Financial Projections Justify Buy Rating
4M ago
RIGL
Rigel Pharmaceuticals: First patient enrolled in Phase 1b study of R289
PremiumThe FlyRigel Pharmaceuticals: First patient enrolled in Phase 1b study of R289
4M ago
RIGL
Eli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment
Premium
Company Announcements
Eli Lilly and Rigel’s Promising Study on Rheumatoid Arthritis Treatment
5M ago
LLY
RIGL
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
Premium
Company Announcements
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth
6M ago
RIGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >